Synairgen PLC (SNG)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
4.50p
Buy
4.79p
-0.035p (-0.77%)
Prices updated at 31 Oct 2024, 16:35 GMT
| Prices minimum 15 mins delay
Prices in GBX
Synairgen PLC is a respiratory drug discovery and development company. It is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, chronic obstructive pulmonary disease.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
30 Oct 202410 Oct 202426 Sep 202418 Sep 202405 Sep 202427 Jun 202415 Nov 202311 Oct 202303 Oct 202321 Sep 2023
Key dates
| Forecast date | |
|---|---|
| Annual general meeting | Oct 2025 |
| Half yearly results | Sep 2025 |
| Final results | Jun 2025 |
| Annual report | Jun 2025 |
| Previous date | |
|---|---|
| Annual general meeting | Oct 2024 |
| Half yearly results | Sep 2024 |
| Final results | Jun 2024 |
| Annual report | Jun 2024 |
Company reports
31 Dec 2022
Annual Report 30 Jun 2012
Quarterly Report 